Literature DB >> 30322885

HDAC1 overexpression enhances β-cell proliferation by down-regulating Cdkn1b/p27.

Carrie Draney1, Matthew C Austin1, Aaron H Leifer1, Courtney J Smith1, Kyle B Kener1, Talon J Aitken1, Kavan H Hess1, Amanda C Haines1, Elle Lett2, Angelina Hernandez-Carretero3, Patrick T Fueger3, Michelle Arlotto2, Jeffery S Tessem4.   

Abstract

The homeobox transcription factor Nkx6.1 is sufficient to increase functional β-cell mass, where functional β-cell mass refers to the combination of β-cell proliferation, glucose-stimulated insulin secretion (GSIS) and β-cell survival. Here, we demonstrate that the histone deacetylase 1 (HDAC1), which is an early target of Nkx6.1, is sufficient to increase functional β-cell mass. We show that HDAC activity is necessary for Nkx6.1-mediated proliferation, and that HDAC1 is sufficient to increase β-cell proliferation in primary rat islets and the INS-1 832/13 β-cell line. The increase in HDAC1-mediated proliferation occurs while maintaining GSIS and increasing β-cell survival in response to apoptotic stimuli. We demonstrate that HDAC1 overexpression results in decreased expression of the cell cycle inhibitor Cdkn1b/p27 which is essential for inhibiting the G1 to S phase transition of the cell cycle. This corresponds with increased expression of key cell cycle activators, such as Cyclin A2, Cyclin B1 and E2F1, which are activated by activation of the Cdk4/Cdk6/Cyclin D holoenzymes due to down-regulation of Cdkn1b/p27. Finally, we demonstrate that overexpression of Cdkn1b/p27 inhibits HDAC1-mediated β-cell proliferation. Our data suggest that HDAC1 is critical for the Nkx6.1-mediated pathway that enhances functional β-cell mass.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Cdkn; Nkx6.1; cell proliferation; histone deacetylases; pancreatic beta cell

Mesh:

Substances:

Year:  2018        PMID: 30322885     DOI: 10.1042/BCJ20180465

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

Review 1.  Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates.

Authors:  Abdelhakim Bouyahya; Naoufal El Hachlafi; Tarik Aanniz; Ilhame Bourais; Hamza Mechchate; Taoufiq Benali; Mohammad Ali Shariati; Pavel Burkov; José M Lorenzo; Polrat Wilairatana; Mohammad S Mubarak; Nasreddine El Omari
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

2.  Decreased proliferation of aged rat beta cells corresponds with enhanced expression of the cell cycle inhibitor p27KIP1.

Authors:  Talon J Aitken; Jacqueline E Crabtree; Daelin M Jensen; Kavan H Hess; Brennan R Leininger; Jeffery S Tessem
Journal:  Biol Cell       Date:  2021-09-27       Impact factor: 4.458

3.  Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease.

Authors:  Ruiwen Wang; Zhecheng Wang; Ruimin Sun; Rong Fu; Yu Sun; Meiyang Zhu; Yunfei Geng; Dongyan Gao; Xiaofeng Tian; Yan Zhao; Jihong Yao
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

4.  Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder Cancer.

Authors:  Yu-Hsiang Lin; Ke-Hung Tsui; Kang-Shuo Chang; Chen-Pang Hou; Tsui-Hsia Feng; Horng-Heng Juang
Journal:  Cancers (Basel)       Date:  2019-12-18       Impact factor: 6.639

5.  Gut Metabolite Trimethylamine N-Oxide Protects INS-1 β-Cell and Rat Islet Function under Diabetic Glucolipotoxic Conditions.

Authors:  Emily S Krueger; Joseph L Beales; Kacie B Russon; Weston S Elison; Jordan R Davis; Jackson M Hansen; Andrew P Neilson; Jason M Hansen; Jeffery S Tessem
Journal:  Biomolecules       Date:  2021-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.